[Form 4] Arcturus Therapeutics Holdings Inc. Insider Trading Activity
Arcturus Therapeutics Holdings Inc. (ARCT) reporting person Andy Sassine, who is identified as both a Director and the Chief Financial Officer, executed a purchase under the companys 2020 Employee Stock Purchase Plan on 08/15/2025. The filing states 1,238 shares were purchased at an effective price of $16.558, which the filer explains was based on 85% of the closing price on that date. Following the reported transaction the filing lists 221,764 shares beneficially owned. The Form 4 is signed by an attorney-in-fact, Ilan Katz, dated 08/19/2025.
Arcturus Therapeutics Holdings Inc. (ARCT): la persona che ha effettuato la comunicazione, Andy Sassine, identificato sia come amministratore sia come Chief Financial Officer, ha acquistato azioni nell'ambito del 2020 Employee Stock Purchase Plan il 15/08/2025. La comunicazione indica l'acquisto di 1.238 azioni a un prezzo effettivo di $16.558, calcolato secondo quanto spiegato dal dichiarante come il 85% del prezzo di chiusura di quella data. Dopo l'operazione la segnalazione riporta la detenzione beneficiaria di 221.764 azioni. Il Modulo 4 猫 firmato per procura da Ilan Katz e datato 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT): la persona informante, Andy Sassine, identificado tanto como Director como Chief Financial Officer, realiz贸 una compra seg煤n el 2020 Employee Stock Purchase Plan el 15/08/2025. La presentaci贸n indica la adquisici贸n de 1.238 acciones a un precio efectivo de $16.558, que el declarante explica se bas贸 en el 85% del precio de cierre de esa fecha. Tras la operaci贸n, la presentaci贸n se帽ala una participaci贸n beneficiaria de 221.764 acciones. El Formulario 4 est谩 firmado por apoderado, Ilan Katz, con fecha 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT)鞚� 氤搓碃鞛� 鞎る敂 靸堨嫚(Andy Sassine)鞚� 鞚挫偓鞚挫瀽 斓滉碃鞛毂呾瀯鞛�(CFO)搿� 頇曥澑霅橂┌, 2020 Employee Stock Purchase Plan鞐� 霐半澕 2025雲� 08鞗� 15鞚�鞐� 欤检嫕鞚� 毵れ垬頄堨姷雼堧嫟. 鞁犼碃靹滌棎電� 1,238欤�毳� 鞙犿毃 臧�瓴� $16.558鞐� 毵れ垬頄堨溂氅�, 鞁犼碃鞚胳潃 頃措嫻 臧�瓴╈澊 攴鸽偁鞚� 膦呹皜鞚� 85%毳� 旮办鞙茧 靷办爼霅橃棃雼り碃 靹る獏頃橁碃 鞛堨姷雼堧嫟. 氤搓碃霅� 瓯半灅 鞚错泟 鞁犼碃靹滌棎電� 221,764欤�鞚� 鞁れ 氤挫湢臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. Form 4電� 雽�毽澑 Ilan Katz臧� 靹滊獏頄堨溂氅� 雮犾電� 2025雲� 08鞗� 19鞚�鞛呺媹雼�.
Arcturus Therapeutics Holdings Inc. (ARCT) : la personne d茅clar茅e, Andy Sassine, identifi茅 脿 la fois comme administrateur et directeur financier, a effectu茅 un achat dans le cadre du 2020 Employee Stock Purchase Plan le 15/08/2025. Le dossier indique l'achat de 1 238 actions 脿 un prix effectif de 16,558 $, que le d茅clarant pr茅cise avoir 茅t茅 calcul茅 sur la base de 85 % du cours de cl么ture de cette date. Apr猫s l'op茅ration, le dossier fait 茅tat d'une d茅tention b茅n茅ficiaire de 221 764 actions. Le formulaire 4 est sign茅 par un mandataire, Ilan Katz, et dat茅 du 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT): Die meldepflichtige Person Andy Sassine, der sowohl als Direktor als auch als Chief Financial Officer ausgewiesen ist, t盲tigte am 15.08.2025 einen Kauf im Rahmen des 2020 Employee Stock Purchase Plan. Die Einreichung gibt an, dass 1.238 Aktien zu einem effektiven Preis von $16,558 erworben wurden, der laut Angabe des Meldenden auf 85% des Schlusskurses dieses Tages basiert. Nach der gemeldeten Transaktion werden 221.764 wirtschaftlich gehaltene Aktien ausgewiesen. Das Formular 4 ist von einem Bevollm盲chtigten, Ilan Katz, unterschrieben und datiert auf 19.08.2025.
- None.
- None.
Insights
TL;DR: Insider purchased shares through the ESPP at a stated 15% discount; transaction appears routine and non-material to valuation.
The filing documents a small-scale, plan-based purchase of 1,238 shares by the CFO/Director under the 2020 ESPP. The purchase price is noted as 85% of the closing price on 08/15/2025, consistent with typical ESPP discounts. The post-transaction beneficial ownership is reported as 221,764 shares. This is a compliance disclosure of insider activity rather than an operational or financial development.
TL;DR: Disclosure aligns with Section 16 reporting; transaction follows an established employee share plan and is procedurally standard.
The Form 4 correctly identifies the reporting persons roles and cites the ESPP as the transaction vehicle. The explanatory footnotes explicitly state the shares were purchased pursuant to the 2020 ESPP and priced at 85% of the issuers closing price. Signature by an attorney-in-fact is included with a date. No indications of atypical timing, derivative exercise, or other governance red flags are present in the text provided.
Arcturus Therapeutics Holdings Inc. (ARCT): la persona che ha effettuato la comunicazione, Andy Sassine, identificato sia come amministratore sia come Chief Financial Officer, ha acquistato azioni nell'ambito del 2020 Employee Stock Purchase Plan il 15/08/2025. La comunicazione indica l'acquisto di 1.238 azioni a un prezzo effettivo di $16.558, calcolato secondo quanto spiegato dal dichiarante come il 85% del prezzo di chiusura di quella data. Dopo l'operazione la segnalazione riporta la detenzione beneficiaria di 221.764 azioni. Il Modulo 4 猫 firmato per procura da Ilan Katz e datato 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT): la persona informante, Andy Sassine, identificado tanto como Director como Chief Financial Officer, realiz贸 una compra seg煤n el 2020 Employee Stock Purchase Plan el 15/08/2025. La presentaci贸n indica la adquisici贸n de 1.238 acciones a un precio efectivo de $16.558, que el declarante explica se bas贸 en el 85% del precio de cierre de esa fecha. Tras la operaci贸n, la presentaci贸n se帽ala una participaci贸n beneficiaria de 221.764 acciones. El Formulario 4 est谩 firmado por apoderado, Ilan Katz, con fecha 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT)鞚� 氤搓碃鞛� 鞎る敂 靸堨嫚(Andy Sassine)鞚� 鞚挫偓鞚挫瀽 斓滉碃鞛毂呾瀯鞛�(CFO)搿� 頇曥澑霅橂┌, 2020 Employee Stock Purchase Plan鞐� 霐半澕 2025雲� 08鞗� 15鞚�鞐� 欤检嫕鞚� 毵れ垬頄堨姷雼堧嫟. 鞁犼碃靹滌棎電� 1,238欤�毳� 鞙犿毃 臧�瓴� $16.558鞐� 毵れ垬頄堨溂氅�, 鞁犼碃鞚胳潃 頃措嫻 臧�瓴╈澊 攴鸽偁鞚� 膦呹皜鞚� 85%毳� 旮办鞙茧 靷办爼霅橃棃雼り碃 靹る獏頃橁碃 鞛堨姷雼堧嫟. 氤搓碃霅� 瓯半灅 鞚错泟 鞁犼碃靹滌棎電� 221,764欤�鞚� 鞁れ 氤挫湢臧� 旮办灛霅橃柎 鞛堨姷雼堧嫟. Form 4電� 雽�毽澑 Ilan Katz臧� 靹滊獏頄堨溂氅� 雮犾電� 2025雲� 08鞗� 19鞚�鞛呺媹雼�.
Arcturus Therapeutics Holdings Inc. (ARCT) : la personne d茅clar茅e, Andy Sassine, identifi茅 脿 la fois comme administrateur et directeur financier, a effectu茅 un achat dans le cadre du 2020 Employee Stock Purchase Plan le 15/08/2025. Le dossier indique l'achat de 1 238 actions 脿 un prix effectif de 16,558 $, que le d茅clarant pr茅cise avoir 茅t茅 calcul茅 sur la base de 85 % du cours de cl么ture de cette date. Apr猫s l'op茅ration, le dossier fait 茅tat d'une d茅tention b茅n茅ficiaire de 221 764 actions. Le formulaire 4 est sign茅 par un mandataire, Ilan Katz, et dat茅 du 19/08/2025.
Arcturus Therapeutics Holdings Inc. (ARCT): Die meldepflichtige Person Andy Sassine, der sowohl als Direktor als auch als Chief Financial Officer ausgewiesen ist, t盲tigte am 15.08.2025 einen Kauf im Rahmen des 2020 Employee Stock Purchase Plan. Die Einreichung gibt an, dass 1.238 Aktien zu einem effektiven Preis von $16,558 erworben wurden, der laut Angabe des Meldenden auf 85% des Schlusskurses dieses Tages basiert. Nach der gemeldeten Transaktion werden 221.764 wirtschaftlich gehaltene Aktien ausgewiesen. Das Formular 4 ist von einem Bevollm盲chtigten, Ilan Katz, unterschrieben und datiert auf 19.08.2025.
